SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-132566
Filing Date
2021-04-27
Accepted
2021-04-27 07:00:31
Documents
5
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d83099ddef14a.htm DEF 14A 441220
2 GRAPHIC g83099g29h45.jpg GRAPHIC 27653
3 GRAPHIC g83099g34t00.jpg GRAPHIC 46461
4 GRAPHIC g83099g37r33.jpg GRAPHIC 381638
5 GRAPHIC g83099g81e73.jpg GRAPHIC 122959
  Complete submission text file 0001193125-21-132566.txt   1239447
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38707 | Film No.: 21855831
SIC: 2836 Biological Products, (No Diagnostic Substances)